Skip to main content
Equibles
PRVA logo

PRVA · Privia Health Group, Inc.

Track PRVA — free

Use PRVA with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about PRVA

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$22.00 +0.24 (+1.10%) At close · Aug 14
Market Cap
$2.81B
Shares
127.73M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$22.00 Open$21.72 Day$21.55–22.25 52W close$20.02–28.10 Avg vol 30d1.3M Short int3.8M · 3.0% float · 3.4d Short vol39% Last earningsAug 6, 2026 DataApr 2021–Aug 2026 Filing10-Q · Aug 6

Up next

Next earnings call
Nov 5, 2026 Est · unconfirmed · in 12 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 6, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Sell
      SellHoldBuy
      Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Excellent Quant / Vol High
      Market backdrop VIX 14.3 · calm Equity put/call 0.52
      Technical
      price trend
      Sell
      50 / 200-day cross No cross
      Price vs 200-day avg −6%
      below
      Price vs 50-day avg −10%
      below
      RSI (14) 33
      neutral
      MACD trend Negative
      52-week position 25%
      mid-range
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Very Weak
      1-month return −18%
      trailing
      6-month return +2%
      trailing
      YTD return −7%
      this year
      Relative strength −12%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $25 › 200d $23 — 50d above 200d
      Institutional flow Accumulating
      +1% holders QoQ · +46 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      3.00% of float · ▲ +4.0% MoM · 3.4 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      297 holders — near 3-yr high, broad support
      Squeeze score 46
      elevated · 0–100
      Fundamentals
      Excellent
      Revenue growth +22%
      Y/Y
      EPS growth +64%
      Y/Y
      Free cash flow $163.3M
      Valuation P/E 100
      rich
      Balance sheet $446.4M
      net cash
      Quant / Vol
      risk profile
      High
      Volatility 33%
      annualized · 1-yr
      Max drawdown −24%
      past year
      ATR 4.4%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed Aug 6, 2026
      Updated FY 2026 Guidance at 8.6.26
      Practice Collections $3,650 – $3,750
      GAAP Revenue $2,350 – $2,450
      Platform Contribution $260 – $270
      Care Margin $515 – $530
      Adjusted EBITDA $145 – $155
      full-year 2026
      Adjusted EBITDA to free cash flow conversion 70% – 80%
      Prior guidance period ended · from the Earnings Call filed Sep 30, 2025
      Attributed lives growth · 2025 12.5%
      Practice collections growth · 2025 17.1%
      Adjusted EBITDA growth · 2025 32%
      Care margin growth · 2025 13.2%
      Cash · year-end 2025 at least $410M

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Sell
      3 · 4 · 0
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −6% Bearish
      Price vs 50-day avg
      −10% Bearish
      RSI (14)
      33 Neutral
      MACD trend
      Negative Bearish
      52-week position
      25% Neutral
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bullish · 2 of 6
      Trend (MA cross) No cross
      50d $25 › 200d $23 — 50d above 200d
      Institutional flow Accumulating
      +1% holders QoQ · +46 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      3.00% of float · ▲ +4.0% MoM · 3.4 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      297 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      Range low $20 Now $22 · 25% Range high $28
      vs 200-day avg -6% vs 50-day avg -10%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Adjusted EBITDA Margin non-GAAP 28.4% Six Months Ended June 30, 2026 —
      Adjusted net income non-GAAP $49.58M Six Months Ended June 30, 2026 —
      Adjusted net income per share attributable to Privia Health Group, Inc. stockholders – basic non-GAAP $0.4 Six Months Ended June 30, 2026 —
      Adjusted net income per share attributable to Privia Health Group, Inc. stockholders – diluted non-GAAP $0.38 Six Months Ended June 30, 2026 —
      Attributed Lives (as of end of period) 1,647,000 Six Months Ended June 30, 2026 —
      Implemented Providers (as of end of period) 5,644 Six Months Ended June 30, 2026 —
      Platform Contribution Margin non-GAAP 52.1% Six Months Ended June 30, 2026 —
      Non-GAAP adjusted net income non-GAAP $24.3M Three Months Ended March 31, 2026 —
      Non-GAAP adjusted net income per share non-GAAP $0.19 Three Months Ended March 31, 2026 —
      Attributed Lives 1,541,000 FY 2025 —
      Free Cash Flow non-GAAP $163.4M FY 2025 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Health Information Services — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      PRVA
      Privia Health Group, Inc.
      this stock
      		$2.81B -7.2% +22.3% 100.0 3.0%
      VEEV
      Veeva Systems Inc
      		 $39.60B +9.2% +28.1% 43.2 4.5%
      PMDIY
      Pro Medicus Ltd./ADR
      		 $14.08B -18.8% — — 0.0%
      BTSG
      BrightSpring Health Services, Inc.
      		 $12.21B +64.8% +28.2% 37.4 4.2%
      TEM
      Tempus AI, Inc.
      		 $9.40B -11.8% +83.4% — 18.4%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      297
      % held
      96.7%
      Net QoQ
      +2.5M sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      292
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      3.8M
      Days to cover
      3.4d
      Change
      +148.6K sh
      View
      Short Volume
      Short vol %
      39%
      As of
      Aug 14, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      15
      Value
      $418
      As of
      Jul 14, 2026
      View
      Off-Exchange
      Off-exchange %
      41.1%
      Week of
      Jul 6, 2026
      Off-exch Lit
      View
      Financials
      Financials
      Net income (FY)
      $22.9M
      EPS diluted
      $0.18
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 6, 2026
      This year
      10
      View
      Proposed Sales
      Value
      $588.6K
      Shares
      21.3K
      Filed
      Jul 9, 2026
      View
      Exempt Offerings
      Offering
      Indefinite
      Filed
      Mar 11, 2020
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 6, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      PRVA -2.0% -18.2% +1.6% -7.1% -7.2%
      SPY +0.4% +4.5% +13.8% +3.9% +13.9%
      vs SPY -2.4% -22.7% -12.2% -11.0% -21.1%
      Key facts CIK 1759655 CUSIP 74276R102 13F (30d) 279 filings 278 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)